2012 Q1 Form 10-K Financial Statement

#000114420412020555 Filed on April 06, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 2010 Q4
Revenue $52.65K $89.32K $50.00K
YoY Change 59.54% -15.78% 400.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $290.0K $1.430M $290.0K
YoY Change 11.54% 28.83% -6.45%
% of Gross Profit
Research & Development $133.5K $942.2K $80.00K
YoY Change 105.35% 100.73% 33.33%
% of Gross Profit
Depreciation & Amortization $1.382K $6.230K $10.00K
YoY Change -10.38% 1.05%
% of Gross Profit
Operating Expenses $133.5K $942.2K $370.0K
YoY Change 105.35% 100.73% 0.0%
Operating Profit
YoY Change
Interest Expense $1.881K $37.19K -$10.00K
YoY Change -93.37% -51.05% -50.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$380.0K -$2.320M -$330.0K
YoY Change 5.56% 52.63% -13.16%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$377.7K -$2.320M -$330.0K
YoY Change 5.92% 52.29% -13.16%
Net Earnings / Revenue -717.41% -2597.84% -660.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.167M -$23.20M -$5.500M
COMMON SHARES
Basic Shares Outstanding 1.247B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q1 2011 2010 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.00K $20.00K $370.0K
YoY Change -90.59% -94.59%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $50.00K $40.00K $20.00K
YoY Change 150.0% 100.0% 100.0%
Inventory
Prepaid Expenses $51.51K $21.77K
Receivables $40.82K $20.00K $7.092K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $173.6K $70.00K $396.0K
YoY Change -80.71% -82.5% 3859.64%
LONG-TERM ASSETS
Property, Plant & Equipment $8.427K $10.00K $15.71K
YoY Change -15.73% -50.0% -21.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0%
Other Assets $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $10.74K $10.00K $18.02K
YoY Change -46.29% 0.0% -69.96%
TOTAL ASSETS
Total Short-Term Assets $173.6K $70.00K $396.0K
Total Long-Term Assets $10.74K $10.00K $18.02K
Total Assets $184.4K $80.00K $414.0K
YoY Change -79.96% -80.49% 491.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $695.0K $700.0K $203.6K
YoY Change 215.92% 250.0% -75.76%
Accrued Expenses $20.00K $10.00K $540.0K
YoY Change -33.33% -98.15% 80.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $400.0K
YoY Change -100.0% -28.57%
Total Short-Term Liabilities $914.5K $730.0K $1.150M
YoY Change 28.8% -36.52% -34.68%
LONG-TERM LIABILITIES
Long-Term Debt $111.8K $110.0K $405.0K
YoY Change -25.48% -72.5% 350.0%
Other Long-Term Liabilities $490.0K $490.0K $490.0K
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $111.8K $600.0K $405.0K
YoY Change -82.53% -32.58% 350.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $914.5K $730.0K $1.150M
Total Long-Term Liabilities $111.8K $600.0K $405.0K
Total Liabilities $1.026M $1.330M $1.555M
YoY Change -23.98% -34.8% -16.42%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $15.47M $12.47M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.328M -$1.250M -$1.626M
YoY Change
Total Liabilities & Shareholders Equity $184.4K $80.00K $414.0K
YoY Change -79.96% -80.49% 491.41%

Cashflow Statement

Concept 2012 Q1 2011 2010 Q4
OPERATING ACTIVITIES
Net Income -$377.7K -$2.320M -$330.0K
YoY Change 5.92% 52.29% -13.16%
Depreciation, Depletion And Amortization $1.382K $6.230K $10.00K
YoY Change -10.38% 1.05%
Cash From Operating Activities -$301.2K -$1.118M -$250.0K
YoY Change 13.08% 118.81% 108.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $998.00 $0.00
YoY Change -69.29%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$998.00 $0.00
YoY Change -69.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 364.8K 770.0K 620.0K
YoY Change -51.36% -12.54% 1140.0%
NET CHANGE
Cash From Operating Activities -301.2K -1.118M -250.0K
Cash From Investing Activities 0.000 -998.0 0.000
Cash From Financing Activities 364.8K 770.0K 620.0K
Net Change In Cash 63.62K -349.4K 370.0K
YoY Change -86.85% -195.48% -628.57%
FREE CASH FLOW
Cash From Operating Activities -$301.2K -$1.118M -$250.0K
Capital Expenditures $0.00 $998.00 $0.00
Free Cash Flow -$301.2K -$1.119M -$250.0K
YoY Change 13.08% 117.63% 108.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1247220696 shares
CY2011Q2 dei Entity Public Float
EntityPublicFloat
19569331
CY2000Q4 us-gaap Stockholders Equity
StockholdersEquity
221212
CY2000Q4 us-gaap Cash
Cash
10
CY2001Q4 us-gaap Stockholders Equity
StockholdersEquity
162972
CY2002Q4 us-gaap Stockholders Equity
StockholdersEquity
112433
CY2003Q4 us-gaap Stockholders Equity
StockholdersEquity
20929
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
-369457
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
-386897
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
-881748
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
-921198
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
-2211746
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-1792157
CY2009Q4 us-gaap Cash
Cash
1118
CY2010Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
403445
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1149571
CY2010Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
404998
CY2010Q4 us-gaap Interest Payable Current
InterestPayableCurrent
41174
CY2010Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7092
CY2010Q4 us-gaap Assets
Assets
413988
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
151508
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
757539307 shares
CY2010Q4 us-gaap Assets Current
AssetsCurrent
395964
CY2010Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
14100651
CY2010Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
59000000 shares
CY2010Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21771
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2010Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
501362
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
413988
CY2010Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12322913
CY2010Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
4120
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-1626230
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
757539307 shares
CY2010Q4 us-gaap Temporary Equity Carrying Amount
TemporaryEquityCarryingAmount
485649
CY2010Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15709
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2010Q4 us-gaap Liabilities
Liabilities
1554569
CY2010Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2315
CY2010Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
203590
CY2010Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
400878
CY2010Q4 us-gaap Cash
Cash
367101
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
729661
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
113444
CY2011Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1799
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17000
CY2011Q4 us-gaap Assets
Assets
82225
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
230501
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1152502875 shares
CY2011Q4 us-gaap Assets Current
AssetsCurrent
70101
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
16421120
CY2011Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
59000000 shares
CY2011Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
113444
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35435
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2011Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
13189
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82225
CY2011Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
16542
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14944090
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-1246529
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1152502875 shares
CY2011Q4 us-gaap Temporary Equity Carrying Amount
TemporaryEquityCarryingAmount
485649
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9809
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2011Q4 us-gaap Liabilities
Liabilities
843105
CY2011Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2315
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
698131
CY2011Q4 us-gaap Cash
Cash
17666
CY2001 us-gaap Net Income Loss
NetIncomeLoss
-259221
CY2001 tdcp Unearned Compensation Changes
UnearnedCompensationChanges
60000
CY2002 us-gaap Net Income Loss
NetIncomeLoss
-267887
CY2002 tdcp Unearned Compensation Changes
UnearnedCompensationChanges
60000
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-51851
CY2003 tdcp Unearned Compensation Changes
UnearnedCompensationChanges
90000
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-592811
CY2005 tdcp Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
174000
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-1469888
CY2006 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
33800
CY2006 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
568500
CY2006 tdcp Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
150000
CY2007 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1274666
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-3928996
CY2007 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
87864
CY2007 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
463920
CY2007 tdcp Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
1677183
CY2010 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
232886
CY2010 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
10467
CY2010 us-gaap Depreciation
Depreciation
6165
CY2010 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
339231
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-1566835
CY2009 tdcp Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
382590
CY2009 tdcp Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
483004
CY2010 us-gaap Stock Issued1
StockIssued1
700063
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
418112
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3250
CY2010 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7092
CY2010 us-gaap Revenues
Revenues
106059
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-511135
CY2010 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
16706
CY2010 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
479490
CY2010 us-gaap Interest Expense
InterestExpense
75969
CY2010 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
400878
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-1523737
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
469408
CY2010 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
279191
CY2010 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
418112
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3250
CY2010 us-gaap Sales Revenue Net
SalesRevenueNet
9697
CY2010 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-17061
CY2010 us-gaap Revenue From Grants
RevenueFromGrants
96362
CY2010 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
365983
CY2010 us-gaap Interest Paid
InterestPaid
33885
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1084419
CY2010 us-gaap Notes Issued1
NotesIssued1
25206
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
880368
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.003
CY2010 tdcp Supplemental Accounts Payable
SupplementalAccountsPayable
485649
CY2010 tdcp Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
518000
CY2010 tdcp Total Costs And Expenses
TotalCostsAndExpenses
1629796
CY2010 tdcp Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
279191
CY2010 tdcp Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
532386253 shares
CY2011 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2011 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2011 dei Trading Symbol
TradingSymbol
TDCP
CY2011 dei Entity Registrant Name
EntityRegistrantName
3DICON CORP
CY2011 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2011 dei Amendment Flag
AmendmentFlag
false
CY2011 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2011 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
CY2011 dei Document Type
DocumentType
10-K
CY2011 dei Document Period End Date
DocumentPeriodEndDate
2011-12-31
CY2011 dei Entity Central Index Key
EntityCentralIndexKey
0001375195
CY2011 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2011 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2011 us-gaap Stock Issued1
StockIssued1
556027
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
285600
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-998
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9908
CY2011 us-gaap Revenues
Revenues
89323
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1118437
CY2011 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
770000
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
355205
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
86323
CY2011 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-349435
CY2011 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13664
CY2011 us-gaap Depreciation
Depreciation
6230
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
534949
CY2011 us-gaap Interest Expense
InterestExpense
37187
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-2320469
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
942240
CY2011 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
703546
CY2011 us-gaap Asset Impairment Charges
AssetImpairmentCharges
668
CY2011 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
285600
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
998
CY2011 us-gaap Nature Of Operations
NatureOfOperations
<div style="font: 10pt Times New Roman, Times, Serif"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <b>Note 1 &#x2013; Organization and Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <i>Organization</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> 3DIcon Corporation (the "Company") was incorporated on August 11, 1995, under the laws of the State of Oklahoma as First Keating Corporation. The articles of incorporation were amended August 1, 2003 to change the name to 3DIcon Corporation. The initial focus of First Keating Corporation was to market and distribute books written by its founder, Martin Keating. During 2001, First Keating Corporation began to focus on the development of 360-degree holographic technology. The effective date of this transition is January 1, 2001, and the financial information presented is from that date through the current period. The Company has accounted for this transition as reorganization and accordingly, restated its capital accounts as of January 1, 2001. From January 1, 2001, the Company's primary activity has been the raising of capital in order to pursue its goal of becoming a significant participant in the development, commercialization and marketing of next generation 3D display technologies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> The mission of the company is to develop (or acquire), commercialize, and market next generation 3D display technologies including auto-stereoscopic (glasses-free) volumetric 360-degree full-color 3D displays and possibly auto-stereoscopic (glasses-free) flat screen 3D displays. Our initial market focus is on business, industrial, and government applications of the technologies. At this time the Company owns no intellectual property in 3D displays but does own the exclusive worldwide rights to commercial and government usage of the 3D display intellectual property developed by the University of Oklahoma.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <i>Uncertainties</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> The accompanying financial statements have been prepared on a going concern basis. The Company is in the development stage and has insufficient revenue and capital commitments to fund the development of its planned product and to pay operating expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> The Company has realized a cumulative net loss of $16,421,120 for the period from inception (January 1, 2001) to December 31, 2011, and a net loss of $2,320,469 and $1,523,737 for the years ended December 31, 2011 and 2010, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> The ability of the Company to continue as a going concern during the next year depends on the successful completion of the Company's capital raising efforts to fund the development of its planned technologies.&#xA0;&#xA0;The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> Management plans to fund the future operations of the Company with existing cash of $17,666, grants and investor funding. Under the terms of the Golden State debentures, Golden State may advance an additional $378,787. The additional advance would be available if the Company filed a registration statement; however, the Company does not plan to file such registration statement. In addition, pursuant to the 4.75% Convertible Debenture due on December 31, 2014, beginning in November 2007, Golden State is obligated to submit conversion notices in an amount such that Golden State receives 1% of the outstanding shares of the Company every calendar quarter for a period of one year. In connection with each conversion, Golden State is expected to exercise warrants equal to 10 times the amount of principal converted. The warrants are exercisable at $10.90 per share. The number of warrants exercisable is subject to certain beneficial ownership limitations contained in the 4.75% Debenture and the warrants ("the Beneficial Ownership Limitations"). The Beneficial Ownership Limitations prevent Golden State from converting on the 4.75% Debenture or exercising warrants if such conversion or exercise would cause Golden State's holdings to exceed 9.99% of the Company's issued and outstanding common stock. Subject to the Beneficial Ownership Limitations, Golden State is required to convert $3,000 of the 4.75% Convertible Debenture and exercise 30,000 warrants per month. Based upon our current stock price, our issued and outstanding shares as of December 31, 2011 and ignoring the impact of the Beneficial Ownership Limitations, the Company may receive up to $981,000 in funding from Golden State as a result of warrant exercises during the year ended December 31, 2012.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> The Company was approved for a matching grant from Oklahoma Center for the Advancement of Science and Technology (&#x201C;OCAST&#x201D;) on November 19, 2008 in the amount of approximately $300,000.&#xA0; There remains $82,176 of grant funds to be provided through the end of the grant period, February 28, 2012.&#xA0;&#xA0;(see Note 5 and Note 14)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> &#xA0;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> Additionally, the Company is continuing to pursue financing through private offering of debt or common stock.</p> </div>
CY2011 us-gaap Sales Revenue Net
SalesRevenueNet
3000
CY2011 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-42952
CY2011 us-gaap Interest Paid
InterestPaid
10493
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1430365
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
770000
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.002
CY2011 tdcp Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
756840
CY2011 tdcp Total Costs And Expenses
TotalCostsAndExpenses
2409792
CY2011 tdcp Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
703546
CY2011 tdcp Weighted Average Number Basic Diluted Shares Outstanding
WeightedAverageNumberBasicDilutedSharesOutstanding
1086576438 shares
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-617875
CY2004 tdcp Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
61000
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
654199
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-3611550
CY2008 tdcp Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
362694
CY2008 tdcp Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
965309
us-gaap Stock Issued1
StockIssued1
1987253
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43529
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17000
us-gaap Revenues
Revenues
283621
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8736861
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
170414
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4488455
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2237995
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
286150
us-gaap Depreciation
Depreciation
27191
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2478828
us-gaap Interest Expense
InterestExpense
434842
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
4309591
us-gaap Net Income Loss
NetIncomeLoss
-16421120
us-gaap Licenses Revenue
LicensesRevenue
25000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4158240
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4257681
us-gaap Asset Impairment Charges
AssetImpairmentCharges
6529
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
292202
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2632578
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43529
us-gaap Sales Revenue Net
SalesRevenueNet
40797
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-141672
us-gaap Revenue From Grants
RevenueFromGrants
217824
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
17656
us-gaap Interest Paid
InterestPaid
301727
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12111659
us-gaap Notes Issued1
NotesIssued1
125909
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8798046
tdcp Supplemental Accounts Payable
SupplementalAccountsPayable
485649
tdcp Total Costs And Expenses
TotalCostsAndExpenses
16704741

Files In Submission

Name View Source Status
0001144204-12-020555-index-headers.html Edgar Link pending
0001144204-12-020555-index.html Edgar Link pending
0001144204-12-020555.txt Edgar Link pending
0001144204-12-020555-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tdcp-20111231.xml Edgar Link completed
tdcp-20111231.xsd Edgar Link pending
tdcp-20111231_cal.xml Edgar Link unprocessable
tdcp-20111231_def.xml Edgar Link unprocessable
tdcp-20111231_lab.xml Edgar Link unprocessable
tdcp-20111231_pre.xml Edgar Link unprocessable
v306742_10k.htm Edgar Link pending
v306742_ex31-1.htm Edgar Link pending
v306742_ex31-2.htm Edgar Link pending
v306742_ex32-1.htm Edgar Link pending
v306742_ex32-2.htm Edgar Link pending